About
Bill Young-Greenwald, PhD, is a bioinformatics leader who has led teams to invent ML algorithms behind multiple IVD and LDT approved diagnostic devices. His expertise spans DNA, RNA, epigenetics and proteomics, across both diagnostics and drug development.
His consulting roots trace back to Monoceros Biosystems and Privileged Insights, where he oversaw more than 30 clients — helping each with designing experiments, running end-to-end bioinformatic analyses, and explaining results with all levels including C-Suites.
He has also co-founded a therapeutics company, and now sets bioinformatics research direction at Guardant Health for several programs — while still taking on select outside consulting work.